GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Other Gross PPE

Albert Labs International (XCNQ:ABRT) Other Gross PPE : C$0.08 Mil (As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International Other Gross PPE?

Albert Labs International's Other Gross PPE for the quarter that ended in Sep. 2023 was C$0.08 Mil.

Albert Labs International's quarterly Other Gross PPE stayed the same from Mar. 2023 (C$0.08 Mil) to Jun. 2023 (C$0.08 Mil) and stayed the same from Jun. 2023 (C$0.08 Mil) to Sep. 2023 (C$0.08 Mil).

Albert Labs International's annual Other Gross PPE stayed the same from . 20 (C$0.00 Mil) to Dec. 2021 (C$0.00 Mil) but then increased from Dec. 2021 (C$0.00 Mil) to Dec. 2022 (C$0.08 Mil).


Albert Labs International Other Gross PPE Historical Data

The historical data trend for Albert Labs International's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International Other Gross PPE Chart

Albert Labs International Annual Data
Trend Dec21 Dec22
Other Gross PPE
- 0.08

Albert Labs International Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.08 0.08 0.08 0.08

Albert Labs International Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Albert Labs International (XCNQ:ABRT) Business Description

Traded in Other Exchanges
N/A
Address
6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6
Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines